We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$3.74B
AUM Growth
-$335M
Cap. Flow
-$614M
Cap. Flow %
-16.42%
Top 10 Hldgs %
21.69%
Holding
674
New
53
Increased
215
Reduced
238
Closed
121

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$107M
2
AAPL icon
Apple
AAPL
+$71.8M
3
TRV icon
Travelers Companies
TRV
+$27.6M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$27.4M
5
AXP icon
American Express
AXP
+$26.9M

Sector Composition

Rank Sector Weight
1 Healthcare 28.7%
2 Financials 10.88%
3 Technology 9.76%
4 Communication Services 9.34%
5 Consumer Staples 9.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GIS icon
101
General Mills
GIS
$19.2B
$9.36M 0.25%
162,336
+118,961
+274% +$6.84M
QRVO icon
102
Qorvo
QRVO
$7.63B
$9.3M 0.25%
182,819
-26,470
-13% -$1.36M
TWX
103
DELISTED
Time Warner Inc
TWX
$9.23M 0.25%
142,661
-32,983
-19% -$2.31M
OMC icon
104
Omnicom Group
OMC
$22.7B
$9.18M 0.25%
121,358
+108,278
+828% +$7.95M
BABA icon
105
Alibaba
BABA
$269B
$9.06M 0.24%
111,443
+25,295
+29% +$1.98M
SYK icon
106
Stryker
SYK
$127B
$9M 0.24%
96,790
+4,142
+4% +$396K
KMB icon
107
Kimberly-Clark
KMB
$36.4B
$8.99M 0.24%
70,628
-124,035
-64% -$14.9M
PRE
108
DELISTED
PARTNERRE LTD
PRE
$8.95M 0.24%
64,053
-845
-1% -$117K
HST icon
109
Host Hotels & Resorts
HST
$16.8B
$8.85M 0.24%
577,024
+387,051
+204% +$6.43M
EBAY icon
110
eBay
EBAY
$48.6B
$8.84M 0.24%
321,850
-439,516
-58% -$12.1M
ISEE
111
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$8.84M 0.24%
112,500
+39,000
+53% +$2.26M
MAS icon
112
Masco
MAS
$16B
$8.57M 0.23%
302,924
-290,747
-49% -$8.28M
WBD icon
113
Warner Bros
WBD
$64.6B
$8.47M 0.23%
317,557
-161,914
-34% -$4.68M
NKTR icon
114
Nektar Therapeutics
NKTR
$2.39B
$8.43M 0.23%
33,347
-7,533
-18% -$1.55M
LEG icon
115
Leggett & Platt
LEG
$1.52B
$8.33M 0.22%
198,137
+25,476
+15% +$1.13M
BKNG icon
116
Booking.com
BKNG
$138B
$8.25M 0.22%
161,850
+115,650
+250% +$6.11M
TSRO
117
DELISTED
TESARO, Inc.
TSRO
$8.24M 0.22%
157,500
+72,000
+84% +$3.44M
ADBE icon
118
Adobe
ADBE
$89.5B
$8.11M 0.22%
86,308
-148,901
-63% -$13.4M
MAR icon
119
Marriott International
MAR
$98.7B
$8.07M 0.22%
120,348
-31,316
-21% -$2.27M
KYNB
120
Kyntra Bio
KYNB
$28.5M
$7.92M 0.21%
10,400
+2,372
+30% +$1.57M
FITB
121
Fifth Third Bancorp
FITB
$52B
$7.9M 0.21%
393,194
-204,096
-34% -$4.04M
SHW icon
122
Sherwin-Williams
SHW
$78.3B
$7.88M 0.21%
91,107
-8,562
-9% -$741K
PSX icon
123
Phillips 66
PSX
$82.9B
$7.86M 0.21%
96,038
-90,479
-49% -$7.81M
KITE
124
DELISTED
Kite Pharma, Inc.
KITE
$7.76M 0.21%
126,000
+37,800
+43% +$2.66M
FOLD
125
DELISTED
Amicus Therapeutics
FOLD
$7.41M 0.2%
764,000
-180,000
-19% -$1.62M

Similar funds

Candriam SCA's Q4 2015 Portfolio in Review

As of Q4 2015, Candriam SCA held 674 positions worth $3.74B, down 8.2% from $4.07B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA withdrew a net $614M in Q4 2015, closing 121 positions and reducing 238 holdings. Its most notable exit was Amgen, an estimated $107M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 29% a quarter earlier, followed by Financials and Technology.

Against the trend, Candriam SCA opened a new position in Alphabet (Google) Class A worth $118M.

  • Candriam SCA's largest Q4 2015 buy was Alphabet (Google) Class A: 3,043,280 shares worth $118M.
  • Candriam SCA added most to Intel in Q4 2015, an estimated $61.2M increase.
  • Candriam SCA's biggest Q4 2015 reduction was Colgate-Palmolive, cutting an estimated $21.3M.
  • Candriam SCA fully exited Amgen in Q4 2015, selling an estimated $107M.
  • Candriam SCA's ten largest holdings make up 22% of its $3.74B portfolio in Q4 2015.
  • Candriam SCA opened 53 new positions and closed 121 in Q4 2015.
  • Candriam SCA's portfolio value fell 8.2% quarter-over-quarter to $3.74B.

Based on Candriam SCA's 13F filing for Q4 2015, filed 25 Jan 2016.